B. Braun is the medical devices company most prolific at making international expansions, followed by Siemens and Medtronic. GlobalData’s medical devices foreign direct investment (FDI) company report highlights the current foreign investments made by leading medical devices investors. Buy the report here.
B. Braun has been the most active medical devices greenfield investor between Q1 2019 and Q1 2024, according to GlobalData’s FDI Projects Database. The parent company has been actively investing through several of its subsidiaries/company divisions.
Smarter leaders trust GlobalData
Greenfield foreign direct investment is when a company invests abroad to establish a new physical presence or expand an existing operation. Greenfield investments create jobs and/or involve a capital investment into the foreign location. Other forms of FDI, such as mergers and acquisitions, are not included as part of this definition.
The majority of B. Braun investments were in the general surgery devices subsector. In fact, 95.2% of its total foreign investments were in this subsector. It also created projects across a further two subsectors.
By business function, most (47.6%) of B. Braun projects were related to manufacturing. Logistics & warehousing and sales, administration & marketing were the next most popular operations undertaken by B. Braun.
The company has been active across six world regions, mainly focused on North America which received 42.9% of the company’s greenfield investments between Q1 2019 and Q1 2024. Its top three destination countries (by number of greenfield FDI projects) were the US, Colombia and France. Combined these three countries account for 60% of its total number of medical devices investments.
B. Braun created more FDI projects in 2019 compared to any other year between Q1 2019 and Q1 2024.
Other leading FDI project generators in the medical devices industry include Siemens, Medtronic, Boston Scientific and Stryker.
The US is the leading source market for outbound medical devices greenfield FDI projects. The country accounts for 30.2% of total outbound medical devices investment projects. There have been 162 unique parent companies from the US that have announced medical devices FDI projects between between Q1 2019 and Q1 2024.
To further understand the top medical devices FDI companies, access GlobalData’s Top Medical Devices Foreign Direct Investment Companies report.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s FDI Projects Database records greenfield FDI throughout the world in real-time. The data can be used to analyse company cross-border expansion activities as well as identify industry, thematic and geographic trends.
